BACKGROUND/PURPOSE: The utility of hepatectomy for @entity1 with metastatic @entity96 from @entity674 ( @entity674 ) was evaluated in the present study. METHODS: Between 1989 and 2001, ten @entity1 with liver @entity3 from GIST (four @entity1 and six @entity1 ; age, 34-77 years) underwent hepatectomy at our hospital. All @entity1 underwent complete resection of the @entity5 and hepatectomy with or without microwave coagulation therapy (MCT) for all detectable @entity99 . RESULTS: The median survival time after hepatectomy was 39 months (range, 1 to 96 months). There was one @entity204 . One @entity1 is still alive with relapse of @entity99 , and the remaining eight @entity1 died of disease (liver in six, peritoneum in one, and bone in one). Relapse of @entity99 occurred in seven @entity1 . The disease-free rate after hepatectomy was 22% at 2 years and 11% at 5 years. The survival times of the four @entity1 who received hepatic arterial chemoembolization for recurrent hepatic @entity3 were 7 months (still alive), 17, 23, and 28 months (average, 19 months). CONCLUSIONS: Our data suggest that aggressive surgery (hepatectomy and MCT) for all detectable @entity99 for recurrent hepatic @entity3 improve survival.

Aggressive surgery for liver XXXX from @entity674 .

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'patient', 'men'] @entity96 :: ('MESH:D008113', 'Disease') :: ['liver tumors'] @entity5 :: ('MESH:D009369', 'Disease') :: ['primary tumor'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastases'] @entity674 :: ('MESH:D046152', 'Disease') :: ['GISTs', 'gastrointestinal stromal tumors'] @entity99 :: ('MESH:D056486', 'Disease') :: ['hepatic tumors', 'hepatic tumors and hepatic arterial chemoembolization'] @entity204 :: ('MESH:D003643', 'Disease') :: ['postoperative death']
@entity3 :: (MESH:D009362,Disease) :: ['metastases']
